ロード中...
MicroRNA in radiotherapy: miRage or miRador?
At least half of all cancer patients will receive radiation therapy. Tumour radioresistance, or the failure to control certain tumours with this treatment, can result in locoregional recurrence; thus there is great interest in understanding the underlying biology and developing strategies to overcom...
保存先:
| 出版年: | Br J Cancer |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4453960/ https://ncbi.nlm.nih.gov/pubmed/25611301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|